On hospital day 7, genetic testing revealed MTHFR C677T (CT genotype) and PAI-1 4G/5G polymorphism, indicating mild increased venous thrombosis risk from metabolic/fibrinolytic defects. This evidence concerns the gene MTHFR and Venous thrombosis.